anti-tumor activity
Evaluation of antimicrobial activity, Minimum Inhibitory Concentration (MIC) & Anti tumor activity of Elettariacardamomum and Ferula assa foetida leaves
6
Synthesis of benzothiazole selenato complexes and determination of its anti-tumor activity
6
Elacestrant (RAD1901) exhibits anti tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors
17
<p>Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid</p>
13
A novel immunomodulatory hemocyanin from the limpet Fissurella latimarginata exhibits outstanding anti tumor activity in melanoma
12
ANTI TUMOR ACTIVITY OF FRUIT EXTRACTS OF MOMORDICA DIOICA ROXB
13
Anti Tumor Activity of Phloretin in Treatment of Induced Hepatocellular Carcinoma in Rats
11
Synthesis of acyl oleanolic acid-uracil conjugates and their anti-tumor activity
11
Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts
12
Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma
12
Artesunate shows potent anti-tumor activity in B-cell lymphoma
12
Synthesis and Anti-Tumor Activity of Oleanolic Acid Derivatives
16
Synthesis and Anti-Tumor Activity of Oleanolic Acid Derivatives
18
Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma
16
Membrane Interactivity of Non-steroidal Anti-inflammatory Drugs: A Literature Review
30
Synthesis of novel β-carboline derivatives with potential antimicrobial and anti helminthic activities
9
IN-VIVO ANTI-TUMOR EFFECT OF 5-FLUOROURACIL LOADED CHITOSAN-SODIUM DEOXYCHOLATE NANOPARTICLES
7
Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
8
Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer
12
Discovery of a small molecule targeting SET-PP2A interaction to overcome BCR-ABL T315I mutation of chronic myeloid leukemia
13